These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30630715)

  • 41. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
    Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K
    Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antituberculosis activity of new N-phenyl-N'-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thioureas.
    Karakuş S; Rollas S
    Farmaco; 2002 Jul; 57(7):577-81. PubMed ID: 12164218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.
    Carta A; Bua A; Corona P; Piras S; Briguglio I; Molicotti P; Zanetti S; Laurini E; Aulic S; Fermeglia M; Pricl S
    Eur J Med Chem; 2019 Jan; 161():399-415. PubMed ID: 30384044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.
    Alegaon SG; Alagawadi KR; Dadwe DH
    Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD
    Wang X; Ahn YM; Lentscher AG; Lister JS; Brothers RC; Kneen MM; Gerratana B; Boshoff HI; Dowd CS
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4426-4430. PubMed ID: 28827112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
    Karale UB; Shinde AU; Babar DA; Sangu KG; Vagolu SK; Eruva VK; Jadav SS; Misra S; Dharmarajan S; Rode HB
    Arch Pharm (Weinheim); 2021 Oct; 354(10):e2000419. PubMed ID: 34185337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.
    Sriram D; Aubry A; Yogeeswari P; Fisher LM
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis.
    Liu P; Yang Y; Ju Y; Tang Y; Sang Z; Chen L; Yang T; An Q; Zhang T; Luo Y
    Bioorg Chem; 2018 Oct; 80():422-432. PubMed ID: 30005200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and biological evaluation of novel 2-methoxypyridylamino-substituted riminophenazine derivatives as antituberculosis agents.
    Zhang D; Liu Y; Zhang C; Zhang H; Wang B; Xu J; Fu L; Yin D; Cooper CB; Ma Z; Lu Y; Huang H
    Molecules; 2014 Apr; 19(4):4380-94. PubMed ID: 24722591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
    Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Wang D; Qin X; Jiang B; Wu W; Liu M; Lu Y
    Bioorg Med Chem; 2022 Jan; 53():116529. PubMed ID: 34861474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel 2-(2-benzylidenehydrazinyl)benzo[d]thiazole as potential antitubercular agents.
    Bairwa VK; Telvekar VN
    Comb Chem High Throughput Screen; 2013 Mar; 16(3):244-7. PubMed ID: 23176058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides.
    Sriram D; Yogeeswari P; Devakaram RV
    Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and synthesis of indolopyridone hybrids as new antituberculosis agents.
    Rather MA; Rasool F; Bhat ZS; Dar HU; Maqbool M; Amin S; Yousuf SK; Ahmad Z
    Microb Pathog; 2017 Dec; 113():330-334. PubMed ID: 29079215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
    Ali MA; Yar MS
    Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and preliminary biological evaluation of novel N-(3-aryl-1,2,4-triazol-5-yl) cinnamamide derivatives as potential antimycobacterial agents: an operational Topliss Tree approach.
    Kakwani MD; Palsule Desai NH; Lele AC; Ray M; Rajan MG; Degani MS
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6523-6. PubMed ID: 21917452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis.
    Surineni G; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2015 Feb; 25(3):485-91. PubMed ID: 25559743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies.
    Reddy DS; Hosamani KM; Devarajegowda HC
    Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (E)-2-(2-Allylidenehydrazinyl)thiazole derivatives: Design, green synthesis, in silico and in vitro antimycobacterial and radical scavenging studies.
    Hublikar M; Kadu V; Dublad JK; Raut D; Shirame S; Makam P; Bhosale R
    Arch Pharm (Weinheim); 2020 Jul; 353(7):e2000003. PubMed ID: 32372473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.